IP Library Granted Patent US 9,050,332
Granted Patent B2
US 9,050,332 · App. 12/122,027 · Granted Jun 9, 2015

Enzyme containing composition, process of producing said composition and its use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,050,332
App. No.
12/122,027
Granted
Jun 9, 2015
Kind
B2
Abstract

The present invention relates to a composition comprising at least one biologically active protease and at least one biologically active glycosidase wherein the proteases and the glycosidases are present in an activity ratio of from 1,000,000:1 to 1:1,000,000 and wherein the composition has a total enzyme activity of at least 2 U/ml. Furthermore, the present invention relates to a process of producing such enzyme comprising composition and to processes of removing caries. Moreover, the invention relates to the use of one or more enzyme comprising compositions for producing a treatment agent for removing caries.

Claims (27)

1. Method of treating and removing carious infected dentin from a carious lesion, the method comprising the steps of:

applying a dental composition to a site of the carious infected dentin, the composition comprising at least one biologically active protease and having a pH value of about 1 to about 4, wherein the composition is applied on the site of carious infected dentin to be treated in a volume of about 0.001 ml to about 0.5 ml; and

allowing the composition to remain in contact with the site of the carious infected dentin for an exposure time in a range of from about 5 seconds to about 5 minutes, to digest at least a portion of the carious infected dentin from the carious lesion; wherein said dental composition comprises:

1 to about 5,000 U/ml solvent collagenase with 1 U corresponding to the conversion of 1 mmol of L-leucine in 5 h at 37° C. and a pH of 7.5 if collagen is used as substrate,

1 to about 45,000 U/ml solvent pepsin with 1 unit corresponding to a ΔE of 0.01 at A280 nm at 37° C. of converted hemoglobin with trichloroacetic acid (TCA), or

10 to about 300 mAnson/ml solvent proteinase K with 1 Anson unit corresponding to 1 μmol Folin-positive amino acid at a pH of 7.5 and 35° C. if hemoglobin is used as substrate.

2. The method according to claim 1 wherein the composition has a viscosity of 10 MPas to 1000 MPas at 25° C.

3. The method according to claim 1 wherein the composition further comprises at least one glycosidase.

4. The method according to claim 1 wherein the composition further comprises at least one rheological additive.

5. The method according to claim 1 wherein the composition comprises at least pepsin and one protease inhibitor.

6. The method according to claim 1 wherein the composition further comprises one or more adjuvants comprising a complexing agent, an enzyme substrate, an enzyme effector, a thickening agent, a preservative agent, a stabilizing agent, or a combination thereof.

7. The method of claim 6 wherein the preservative agent comprises a para hydroxyl benzoic acid ester.

8. The method of claim 7 wherein the para hydroxyl benzoic acid ester comprises a methyl para hydroxyl benzoic ester, a propyl para hydroxyl benzoic acid ester, or a combination thereof.

9. The method according to claim 1 further comprising the step of identifying the carious infected dentin to be treated.

10. The method according to claim 1 further comprising the step of rinsing the treated carious infected dentin with water.

11. The method according to claim 1 wherein the dental composition comprises

a first component comprising

a protease having its proteolytic activity at a pH value of below 7,

water,

a buffer system providing for a pH value above the pH value at which the protease is most active, and

a second component comprising

water,

an acid providing for a pH value of less than or equal to the pH value at which the protease is most active; and

wherein the method further comprises mixing the first component and the second component to provide the dental composition.

12. The method according to claim 1 wherein the dental composition is applied on the site of carious infected dentin to be treated in two or more treatment steps.

13. The method of claim 1 wherein the composition further comprises one or more preservatives in an amount ranging from 0.001-1 wt.-% based on the weight of the composition.

14. The method of claim 1 wherein the composition further comprises one or more preservatives in an amount ranging from 0.01-0.25 wt.-% based on the weight of the composition.

Assignments (1)
MERGER Recorded Feb 27, 2012
From: 3M ESPE AG
To: 3M DEUTSCHLAND GMBH
Reel/Frame 027762/0754 →